The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 TB 500 Erectile Dysfunction Effects: What Users and Research Actually Report FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) BPC TB 500 Mix C2 Peptides